VERU
USDVeru Inc. Common Stock
$0.653-0.007 (-1.061%)
リアルタイム価格
Healthcare
バイオテクノロジー
米国
価格チャート
Loading Chart...
主要指標
市場指標
始値
$0.660
高値
$0.685
安値
$0.612
出来高
1.69M
企業ファンダメンタルズ
時価総額
95.7M
業種
バイオテクノロジー
国
United States
取引統計
平均出来高
2.33M
取引所
NCM
通貨
USD
52週レンジ
安値 $0.45現在値 $0.653高値 $1.42
関連ニュース
GlobeNewswire
Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide Alone
--Phase 2b QUALITY clinical study topline safety data shows that the enobosarm + semaglutide combination had a positive safety profile compared to semaglutide alone-- --Based on Phase 2b QUALITY trial efficacy and
もっと見る
GlobeNewswire
Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress
--Unblinded safety data from Phase 2b QUALITY study expected in the second quarter of calendar 2025 -- --Topline efficacy and safety data for Phase 2b extension maintenance study expected in the second quarter of
もっと見る
